Shot in the arm for UK funding

The Wellcome Trust, the UK's largest independent funder of biomedical research, linkurl:announced;http://www.wellcome.ac.uk/doc_WTX043044.html yesterday (Feb 5) that it will increase its spending from about £2.5 billion (roughly 4.9 billion USD) over the last five years to about £4 billion (roughly 7.8 billion USD) over the next five years. The trust said that it will put more money towards large-scale genetic studies, neuroscience research, and new technologies and facilities such

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The Wellcome Trust, the UK's largest independent funder of biomedical research, linkurl:announced;http://www.wellcome.ac.uk/doc_WTX043044.html yesterday (Feb 5) that it will increase its spending from about £2.5 billion (roughly 4.9 billion USD) over the last five years to about £4 billion (roughly 7.8 billion USD) over the next five years. The trust said that it will put more money towards large-scale genetic studies, neuroscience research, and new technologies and facilities such as the linkurl:UK Centre for Medical Research and Innovation.;http://www.the-scientist.com/blog/display/53962/ The UK funding boost is cheerier news than President Bush's proposed linkurl:FY 2009 budget,;http://www.the-scientist.com/blog/display/54277/ which cast a cloud over the future US science funding landscape earlier this week.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo